Antimalarial medication "Lariam". Lariam is fairly expensive at around 3 € per tablet (pricing of the year 2000). A dose of 15–25 mg/kg is recommended, depending on the prevalence of mefloquine resistance. The increased dosage is associated with a much greater level of intolerance, most noticeably in young children; with the drug inducing vomiting and esophagitis. It was not recommended for use during the first trimester, although considered safe during the second and third trimesters; nevertheless, in October 2011, the Centers for Disease Control and Prevention (CDC) changed its recommendation and approved use of Mefloquine for both prophylaxis and treatment of malaria
International Association for the Treatment of Sexual Offenders either individual, couple, family, or even group settings. The treatments offered are created and used to prevent any offending behavior and further victimization of others. The biomedical treatment is the use of pharmacological treatment. This type of therapy in the past has included the use of anti-androgens, antidepressants, and anti-anxiety, anti epileptic, antipsychotic, or other types of medicine. However, note that biomedical treatment is not limited to these medications. All medications have different turnouts for different individuals, so it is crucial to find the best fit and the most successful medication for that specific person to help treat them and